Table 2.

Expression of MHC proteins on EBV-transformed B-cell lines


Cells

Background

W6/32

BBM-1

HLA-DQ

HLA-DR

HLA-A3
EBV-A   2.5 ± 0.5   122.5 ± 4.9   12.5 ± 2.1   22.5 ± 2.1   91.5 ± 23.3   2.5 ± 0.5  
EBV-B   3 ± 0.5   106.5 ± 2.1   8 ± 4.2   24 ± 2.8   99.5 ± 14.8   2.8 ± 0.6  
EBV-C   2 ± 0.4   76 ± 1.4   7.35 ± 2.9   29.5 ± 4.9   114.5 ± 17.7   3.0 ± 0.5  
EBV-mother
 
3.5 ± 0.5
 
1300 ± 141
 
155 ± 35
 
35 ± 7.1
 
122.5 ± 10.6
 
110 ± 15
 

Cells

Background

W6/32

BBM-1

HLA-DQ

HLA-DR

HLA-A3
EBV-A   2.5 ± 0.5   122.5 ± 4.9   12.5 ± 2.1   22.5 ± 2.1   91.5 ± 23.3   2.5 ± 0.5  
EBV-B   3 ± 0.5   106.5 ± 2.1   8 ± 4.2   24 ± 2.8   99.5 ± 14.8   2.8 ± 0.6  
EBV-C   2 ± 0.4   76 ± 1.4   7.35 ± 2.9   29.5 ± 4.9   114.5 ± 17.7   3.0 ± 0.5  
EBV-mother
 
3.5 ± 0.5
 
1300 ± 141
 
155 ± 35
 
35 ± 7.1
 
122.5 ± 10.6
 
110 ± 15
 

EBV-transformed B-cell lines were made from the indicated individuals. Cell lines were stained by various mAbs in the form of F(ab′)2 as indicated and analyzed by FACS. Background was the secondary mAb in the form of F(ab′)2. Data are presented as the average MFI of 3 independent experiments ± SD.

Close Modal

or Create an Account

Close Modal
Close Modal